AVCNFAvicanna Inc.

About Avicanna Inc. (AVCNF)

Avicanna Inc. (AVCNF) is a Drug Manufacturers - Specialty & Generic company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the OTCQX tier.

Avicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products via its two main business segments, cultivation and research & development. With its majority-owned subsidiary Santa Marta Golden Hemp S.A.S., located in Santa Marta, Colombia as the base for Avicanna's cultivation activities. These companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including CBD and THC. Avicanna's research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto.

Products and services

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. Avicanna is an established leader in cannabinoid research and development. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including: • RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nationwide across Canada in medical channels in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart, and in adult use channels through provincial retailers. RHO Phyto is the first medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigor, manufactured under GMP standards and supported by pre-clinical data; and, • Pura H&W™: an advanced and clinically tested line of functional CBD consumer derma-cosmetic products currently available nationwide across Canada in medical channels in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart, in adult use channels through provincial retailers in Canada and nation-wide across Colombia.

AVCNF key facts

Ticker symbol

AVCNF

Market tier

OTCQX

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

2016

Employees

85

Estimated market cap

$19.02M (as of Apr 9, 2025)

Shares outstanding

111,860,724

Reporting standard

International Reporting: Toronto Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2024)

Avicanna Inc. leadership

• Aras Azadian — CEO
• Phillip S Cardella — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with A